|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM27699096X |
003 |
DE-627 |
005 |
20231225013217.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2018 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2017.10.001
|2 doi
|
028 |
5 |
2 |
|a pubmed24n0923.xml
|
035 |
|
|
|a (DE-627)NLM27699096X
|
035 |
|
|
|a (NLM)29030294
|
035 |
|
|
|a (PII)S1521-6616(17)30688-5
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Volpi, Stefano
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Type I interferon pathway activation in COPA syndrome
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 18.03.2019
|
500 |
|
|
|a Date Revised 21.01.2021
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2017. Published by Elsevier Inc.
|
520 |
|
|
|a Mutations of the COPA gene cause an immune dysregulatory disease characterised by polyarticular arthritis and progressive interstitial lung disease with pulmonary haemorrhages. We report the case of a young girl that presented at age 3 with polyarticular arthritis, chronic cough and high titer rheumatoid factor. Radiologic imaging showed interstitial lung disease with tree-in-a-bud nodules and air-filled cysts. Targeted genetic analysis of COPA gene showed the reported c.698G>A mutation. The patient was lost to follow up for 3years during which therapy was discontinued with the development of joint damage and deformities. Analysis of peripheral blood showed activation of type 1 interferon pathway, which was also confirmed in 4 previously reported COPA patients. Our observations underline the importance of early treatment in COPA disease to avoid loss of joint function. Furthermore, our results suggest a role for type 1 interferon in disease pathogenesis opening the possibility for targeted therapeutic approaches
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Autoinflammatory diseases
|
650 |
|
4 |
|a COPA syndrome
|
650 |
|
4 |
|a Type 1 interferonopathy
|
650 |
|
7 |
|a Antibodies, Antinuclear
|2 NLM
|
650 |
|
7 |
|a Coatomer Protein
|2 NLM
|
650 |
|
7 |
|a Interferon Type I
|2 NLM
|
650 |
|
7 |
|a Rheumatoid Factor
|2 NLM
|
650 |
|
7 |
|a 9009-79-4
|2 NLM
|
700 |
1 |
|
|a Tsui, Jessica
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Mariani, Marcello
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Pastorino, Claudia
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Caorsi, Roberta
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Sacco, Oliviero
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ravelli, Angelo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Shum, Anthony K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Gattorno, Marco
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Picco, Paolo
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 187(2018) vom: 20. Feb., Seite 33-36
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:187
|g year:2018
|g day:20
|g month:02
|g pages:33-36
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2017.10.001
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 187
|j 2018
|b 20
|c 02
|h 33-36
|